| Updated:
Johnson & Johnson: Covid booster dose sharply increases levels of antibodies
A booster dose of Johnson & Johnson’s Covid-19 vaccine sharply increased levels of antibodies, according to interim data from two early-stage trials, the company said late last night. Watch the full report.
[brid video=”851356″ player=”24372″ title=”J&J%20says%20booster%20shot%20vastly%20increases%20antibdody” duration=”95″ description=”A booster dose of Johnson & Johnson’s COVID-19 vaccine sharply increased levels of antibodies, according to interim data from two early-stage trials, the company said in a press release on Wednesday. Conway G. Gittens reports.” uploaddate=”2021-08-25″ thumbnailurl=”//cdn.brid.tv/live/partners/18445/thumb/851356_t_1629907600.png” contentUrl=”//cdn.brid.tv/live/partners/18445/sd/851356.mp4″]